Marlène Rey

Associate Director at Siparex Proximité Innovation SAS

Marlène Rey

Marlène Rey

Associate Director at Siparex Proximité Innovation SAS

Biography

Ms. Marlène Rey is an Associate Director at Siparex Proximité Innovation SAS. She is on the Board of Directors at Biospace Lab SA.Ms. Rey also served on the board at EOS Imaging SA.

Overview
RelSci Relationships

84

Number of Boards

2

Relationships
RelSci Relationships are individuals Marlène Rey likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Director at Biospace Lab SA

Relationship likelihood: Strong

Partner, Life Sciences at Andera Partners SCA

Relationship likelihood: Strong

Former Member-Management Board & Director-Participations at Siparex Proximité Innovation SAS

Relationship likelihood: Strong

Chief Executive Officer at Step Pharma SAS

Relationship likelihood: Strong

Chief Executive Officer at EOS Imaging SA

Relationship likelihood: Strong

Investment Manager at SIGEFI Private Equity SA

Relationship likelihood: Strong

Investment Director at BPIFrance Investissement SAS

Relationship likelihood: Strong

Director at Stage Capital Ventures

Relationship likelihood: Strong

Vice President & MD-Europe Corporate Development at Danaher Corporation

Relationship likelihood: Strong

Head, Investor Relations at Siparex Proximité Innovation SAS

Relationship likelihood: Strong

Paths to Marlène Rey
Potential Connections via
Relationship Science
You
Marlène Rey
Associate Director at Siparex Proximité Innovation SAS
Career History
Associate Director
2010 - Current

Siparex Proximité Innovation SAS is a private equity investment manager following a diversity of investment strategies. The firm invests direct equity in small and medium-sized companies across development stages, generally acquires minority stakes and follows a hands-on investment approach. They invest 0.5 to 3 million Euros of venture capital in emerging high-growth technology companies, primarily in France and Europe. Their venture capital activity focuses strongly on the regions covered by their parent bank Crédit Mutuel Nord Europe, namely northern France, Belgium and Luxembourg. In terms of expansion financing, they acquire minority stakes in established profitable companies, investing between 1 and 5 million Euros per deal. Their LBO investments amount to 2 to 6 million Euros per operation including mezzanine financing, and target companies with stable cash flow and international expansion potential. Siparex Proximité Innovation SAS favors sectors such as distribution, industry, services, specialized retail and consumer goods.The firm's multimanager strategy is invested in venture capital funds and private equity funds including vehicles focused on expansion financing, LBO and mezzanine, in partnership with the UK bank Schroders. Siparex Proximité Innovation SAS's fund of fund is invested in France, Europe, the US, and marginally in Asia and emerging countries. The firm targets both primary funds and the secondary market, and aims to manage a portfolio diversified across regions, sectors and maturity stages. They favor funds focused on LBO operations and expansion financing.

Investment Manager
Prior

Sud Partners invests venture capital in science-based businesses with high-growth potential in the life sciences and technology sectors. They favor investments in south-eastern France, and usually co-invest with other venture capital firms specialized in biotechnologies.

Boards & Committees
Director
Current

Biospace Lab SA develops and produces imaging tools. Its products include dynamic optical imaging systems and ultrafast real time digital autoradiography solutions. The company was founded by Georges Charpak in 1989 and is headquartered in Nesles la Vallée, France.

Director
Prior - 2013

EOS Imaging SA develops and markets advanced imaging and imaged-based solutions for diagnosing, treating and monitoring the most common musculoskeletal pathologies. It develops low dose medical imaging system(EOS), 2D/3D workstation (sterEOS) and a suite of online, 3D surgical planning solutions for the spine, hip and knee (EOSapps). The company was founded on March 8, 1989 and is headquartered in Paris, France.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Marlène Rey. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Marlène Rey's profile does not indicate a business or promotional relationship of any kind between RelSci and Marlène Rey.